Stuart Needleman is the Chief Commercial Officer at Piramal Pharma Solutions (PPS), where he leads all global business development activities. Delivering a portfolio of services that spans discovery to clinical and commercial supply of both drug substances and drug products, Mr. Needleman has guided the business development team to record results during his tenure. He has a track record of driving sustainable growth at attractive margins and has experience in developing seamless, integrated drug development and manufacturing solutions.

Mr. Needleman also serves as Chief Patient Centricity Officer for PPS, where his mission is to facilitate patient-centric behavior across the global organization. In this position, he ensures that employees at every level of the company – from the production floor to the C-Suite – understand the role they play in the company’s objective of helping to reduce the burden of disease on patients.

Mr. Needleman has close to three decades of experience in the pharmaceutical services industry and is an authority on the contract services segment, having held leadership roles in global business development, sales and marketing, and operations. Before joining PPS, Mr. Needleman served as President of Laurus Synthesis, a subsidiary of Laurus Labs, and as President and Chief Operating Officer of Aptuit, a global contract services company. During his career, he also held key roles at Cambrex, Oxford Asymmetry, ChiRex, and Rhodia Pharma Solutions.

Mr. Needleman has a Bachelor of Science Degree in Chemical Engineering and an MBA from Rensselaer Polytechnic Institute (RPI).